P–325 The impact of letrozole on endometrial thickness in IVF cycles

来曲唑 保持生育能力 医学 妇科 子宫内膜癌 生育率 胚胎移植 乳腺癌 妊娠率 怀孕 产科 癌症 内科学 三苯氧胺 生物 人口 环境卫生 遗传学
作者
Jacob Ruiter‐Ligeti,Suha Arab,William Buckett
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:36 (Supplement_1)
标识
DOI:10.1093/humrep/deab130.324
摘要

Abstract Study question Does daily administration of letrozole during IVF stimulation affect endometrial thickness ? Summary answer Patients treated with letrozole during fresh IVF cycles had a thinner endometrium on the day of trigger compared to patients who did not receive letrozole. What is known already Letrozole supplementation is commonly used during fertility preservation for breast cancer patients to reduce peak estrogen levels with no adverse effects on embryo outcomes. Studies in poor responders have found that letrozole use resulted in a shorter duration of stimulation and a lower total dose of gonadotropin, with no detrimental effect on IVF outcomes. In normal responders, studies have shown an increase in blastocysts obtained, but have not yet shown an increase in clinical pregnancy rates. There is concern that when a fresh embryo transfer is planned letrozole use may negatively affect endometrial thickness and subsequently diminish pregnancy rates. Study design, size, duration In a retrospective cohort study between January 2009 and June 2019 at a single academic fertility center, we compared the endometrial thickness in 97 cancer patients who underwent IVF-fertility preservation with daily letrozole use to 158 cancer patients who underwent IVF-fertility preservation without letrozole. Participants/materials, setting, methods All women diagnosed with cancer were referred for fertility preservation prior to gonadotoxic treatment exposure and were less than 40 years old at the time of oocyte retrieval. All patients who received letrozole started on day one of stimulation and continued until the day of oocyte retrieval. The primary outcome was endometrial thickness on the day of trigger. The secondary outcomes were number of oocytes retrieved, number of MII retrieved, and maximal estradiol level. Main results and the role of chance During the study period, 336 cancer patients underwent fertility preservation. Eighty-one patients were excluded; 50 because they had an intrauterine device or were on long term oral contraceptives and 31 because endometrial thickness was not documented. Of the remaining 255 patients, 86 had breast cancer, 95 had a hematological cancer and 74 had various other cancers. Ninety-seven cancer patients treated with letrozole were compared to 158 cancer patients who did not receive letrozole. Patients who received letrozole were significantly older (34 vs 28yrs, P < 0.0001). There were no significant differences in baseline characteristics such as BMI, AFC nor in the total duration for stimulation. Endometrial thickness on the day of trigger was significantly less in letrozole treated patients (8 vs 9mm, P < 0.003). There were no significant differences in total number of oocytes retrieved (12.5 vs 11, P = 0.126) nor in the number of mature oocytes (8 vs 8, P = 0.312). Patients in the letrozole group received a higher total gonadotropin dose (2680IU vs 1980IU, P = 0.016). The maximum estradiol level was significantly lower in patients treated with letrozole (1068 vs 3838ml/dl, P = <0.0001). A regression analysis showed that using letrozole during stimulation decreased the endometrial thickness by 0.81mm (CI –1.37 to –0.253, P = 0.005). Limitations, reasons for caution The retrospective nature of this study could have introduced selection and misinformation bias. We report on cancer patients where all oocytes or embryos were vitrified. Without fresh embryo transfer data, it is unclear if a thinner endometrium due to letrozole will effect the implantation or pregnancy rate. Wider implications of the findings: As the use of letrozole expands beyond cancer patients and poor responders, it is important to understand the impact on the endometrium. This study shows that letrozole reduces endometrial thickness. However, the effect on endometrial function remains unknown. Further study is needed before letrozole can be used with fresh transfers. Trial registration number 2020–6370

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
果冻橙发布了新的文献求助10
刚刚
xixi发布了新的文献求助10
刚刚
华仔应助Zenobia采纳,获得10
1秒前
2秒前
2秒前
学呀完成签到,获得积分10
2秒前
幸福胡萝卜完成签到,获得积分10
3秒前
健忘鞋垫完成签到,获得积分10
4秒前
AZURE完成签到,获得积分10
5秒前
lbj发布了新的文献求助10
5秒前
量子星尘发布了新的文献求助10
5秒前
白了个白发布了新的文献求助20
5秒前
完美世界应助嘟嘟采纳,获得10
6秒前
bobochi发布了新的文献求助30
6秒前
bm完成签到,获得积分10
7秒前
7秒前
羽羽完成签到 ,获得积分10
8秒前
xiaoxia完成签到,获得积分10
9秒前
11秒前
顾矜应助inferyes采纳,获得10
12秒前
oleskarabach发布了新的文献求助10
12秒前
听曲散步完成签到,获得积分10
13秒前
qq发布了新的文献求助10
14秒前
paltahun发布了新的文献求助10
14秒前
14秒前
科研民工李完成签到,获得积分10
14秒前
14秒前
娜娜完成签到 ,获得积分10
15秒前
L2发布了新的文献求助30
16秒前
花花猪1989发布了新的文献求助20
17秒前
李思发布了新的文献求助10
19秒前
liyq完成签到,获得积分10
20秒前
暮光微凉发布了新的文献求助10
20秒前
yang完成签到,获得积分10
21秒前
十一完成签到,获得积分10
21秒前
21秒前
22秒前
22秒前
lbj完成签到,获得积分20
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance 500
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969940
求助须知:如何正确求助?哪些是违规求助? 3514642
关于积分的说明 11175298
捐赠科研通 3249947
什么是DOI,文献DOI怎么找? 1795178
邀请新用户注册赠送积分活动 875617
科研通“疑难数据库(出版商)”最低求助积分说明 804891